[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345501-105":59,"doc-detail-345501-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","sputum-liquid-biopsy-for-lung-cancer-screening-diagnosis-subtyping-surveillance-response-prediction-and-prognostication-a-scoping-review","Sputum Liquid Biopsy for Lung Cancer Screening, Diagnosis, Subtyping, Surveillance, Response Prediction, and Prognostication: A Scoping Review","","Liquid biopsy enables minimally invasive tumor profiling, yet most clinical research centers on blood specimens. This scoping review evaluates sputum as a non-invasive, readily available respiratory sample for lung cancer care. It systematically maps studies reporting sputum-derived biomarkers across cytologic, genomic, epigenetic, transcriptomic, proteomic, metabolomic, metagenomic, and extracellular vesicle–derived products, extracting designs, technologies, clinical contexts, and outcomes. Findings show high heterogeneity and suggest potential for detection, risk stratification, molecular subtyping, monitoring, prognostication, and surveillance, but highlight limited prospective validation and translational gaps.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/sputum-liquid-biopsy-for-lung-cancer-screening-diagnosis-subtyping-surveillance-response-prediction-and-prognostication-a-scoping-review/345501/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/sputum-liquid-biopsy-for-lung-cancer-screening-diagnosis-subtyping-surveillance-response-prediction-and-prognostication-a-scoping-review/345501.png","ImageObject",300,407,{"name":92,"@type":93},"Theodore","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-28","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why is sputum considered an alternative to blood liquid biopsy for lung cancer?","Question",{"text":112,"@type":113},"Sputum is a non-invasive, readily available respiratory specimen. Compared with blood-focused research, it may provide unique advantages for lung cancer profiling and monitoring.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What major limitation is identified in the current sputum liquid biopsy evidence?",{"text":117,"@type":113},"Evidence shows substantial heterogeneity, and few studies report prospective validation, direct comparison with blood-based liquid biopsy, or demonstrated impact on patient outcomes.",{"name":119,"@type":110,"acceptedAnswer":120},"What future research directions does the review recommend?",{"text":121,"@type":113},"It calls for standardization, prospective validation, assessment of patient-outcome impact, and integration with blood- and other body fluid–based liquid biopsy, alongside development of imaging biomarkers.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345501,1790143998,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":26,"language":139,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":140,"faqs":141,"seo_title":142,"seo_description":67,"update_tm":143,"read_time":144,"preview_page_count":29,"preview_urls":145},7971461740886,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Review  \nSputum Liquid Biopsy for Lung Cancer Screening, Diagnosis, Subtyping, Surveillance, Response Prediction, and Prognostication: A Scoping Review  \nAbdul Rehman 1, *, Muhammad Awais 2, Hafiza Noor Ul Ain Baloch 1, Muhammad Omer Leghari 1, Arfa Ahmad 1 and Hafiz Javed 1  \nAcademic Editor: Ravi P. Sahu  \nReceived: 1 April 2026  \nRevised: 25 April 2026  \nAccepted: 27 April 2026  \nPublished: 30 April 2026  \nCopyright: © 2026 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license.  \n1 Department of Medicine, TidalHealth Peninsula Regional, Salisbury, MD 21801, USA; [noor2000_2004@hotmail.com](noor2000_2004@hotmail.com) (H.N.U.A.B.); [muhammad-omer.leghari@tidalhealth.org](muhammad-omer.leghari@tidalhealth.org) (M.O.L.); [arfa.ahmad@tidalhealth.org](arfa.ahmad@tidalhealth.org) (A.A.); [hafiz.javed@tidalhealth.org](hafiz.javed@tidalhealth.org) (H.J.)  \n2 Department of Radiology, Aga Khan University Hospital, Karachi 74800, Sindh, Pakistan; [awais_aku@yahoo.com](awais_aku@yahoo.com)  \n* Correspondence: [abdul.rehman_aku@yahoo.com](abdul.rehman_aku@yahoo.com); Tel.: +1-410-543-7536  \nAbstract  \nBackground/Objectives: Liquid biopsy (LB) is transforming cancer care by enabling minimally invasive tumor profiling. While current research and clinical pathways mostly focus on blood LB, sputum represents a non-invasive, readily available respiratory specimen that may offer unique advantages for lung cancer (LC) care. Despite its potential, the maturity, breadth, and clinical applicability of sputum-based LB remain elusive. Methods: We conducted a scoping review to systematically map the existing literature on sputum LB in LC. Electronic databases were searched for studies evaluating sputum-derived biomarkers—cytologic, genomic, epigenetic, transcriptomic, proteomic, metabolomic, metagenomic, and extracellular vesicle–derived products—across the LC care continuum. Study designs, technologies, clinical contexts, and reported outcomes were extracted and synthesized qualitatively. Results: The literature demonstrated substantial heterogeneity in sputum collection, processing, and analytical platforms. Early work focused on cytometry and genetic alterations, while recent studies increasingly explore DNA methylomics, microRNAs, extracellular vesicle-derived products, and multi-omics approaches. The evidence suggests potential utility of sputum biomarkers for early detection and risk stratification, particularly in high-risk populations, with emerging data supporting roles in molecular subtyping, response monitoring, prognostication, and surveillance. However, few studies report prospective validation, direct comparison with blood-based LB, or impact on actual patient outcomes. Conclusions: Sputum LB is a promising yet underdeveloped modality in LC care. This scoping review highlights technological innovations alongside significant methodological heterogeneity and translational gaps. Future research should focus on standardization, prospective validation, impact on patient outcomes, and integration with blood-and other body fluid–based LB, as well as imaging biomarkers. This will enable incorporation of sputum-based LB into actual clinical pathways of LC care.  \nKeywords: lung neoplasms; liquid biopsy; tumor biomarkers; neoplasm genetic markers; sputum; circulating tumor DNA; cell-free nucleic acids; circulating tumor cells  \n1. Introduction  \nLung cancer (LC) remains the third most commonly diagnosed cancer in adults and is the most common cause of cancer-related deaths worldwide [1–3] . The American Cancer  \nSociety estimates that, during the year 2026, 229,410 new cases of LC will be diagnosed and 124,990 deaths will be caused by LC—which is more than the cancer-related deaths caused by colorectal cancer and pancreatic cancer combined [2] . Similar trends are reported for European countries: it is estimated that ","cbCaimfwP5FoQAu7","https://ap.wps.com/l/cbCaimfwP5FoQAu7","pdf",16284984,"English","# Abstract\n## Background/Objectives\n## Methods\n## Results\n## Conclusions\n# 1. Introduction\n## Lung cancer burden and need for better detection\n## Role of minimally invasive approaches and liquid biopsy","[{\"question\":\"Why is sputum considered an alternative to blood liquid biopsy for lung cancer?\",\"answer\":\"Sputum is a non-invasive, readily available respiratory specimen. Compared with blood-focused research, it may provide unique advantages for lung cancer profiling and monitoring.\"},{\"question\":\"What major limitation is identified in the current sputum liquid biopsy evidence?\",\"answer\":\"Evidence shows substantial heterogeneity, and few studies report prospective validation, direct comparison with blood-based liquid biopsy, or demonstrated impact on patient outcomes.\"},{\"question\":\"What future research directions does the review recommend?\",\"answer\":\"It calls for standardization, prospective validation, assessment of patient-outcome impact, and integration with blood- and other body fluid–based liquid biopsy, alongside development of imaging biomarkers.\"}]","Sputum Liquid Biopsy for Lung Cancer Screening, Diagnosis, Subtyping, Surveillance, Response Prediction, and Prognostication: A Scoping Review | PDF",1790057897,151,[146,150,154,158,162,166],{"page_no":8,"url":147,"width":148,"height":149},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e30db6b6939602c48b18174e8f6af153.webp",983,1390,{"page_no":14,"url":151,"width":152,"height":153},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/027b9bf2b130630a058c61da0fc89d11.webp",982,1388,{"page_no":81,"url":155,"width":156,"height":157},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/376f0a35bccfc2b5e78c056563b8b881.webp",981,1387,{"page_no":19,"url":159,"width":160,"height":161},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/9c78662d476adb47387ab6ab44ae73f0.webp",980,1385,{"page_no":24,"url":163,"width":164,"height":165},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6e2ee5e88901097553931eb70ba0b783.webp",979,1384,{"page_no":29,"url":167,"width":168,"height":169},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f341c5b5d3ebdb3179a5c4f91b935286.webp",978,1383]